Background Treatment of drug-resistant tuberculosis is often more complex and toxic with
longer treatment time and poor treatment outcomes including treatment failure or death …

Aims and Objectives: The aim of the study is to detect the pattern of genetic mutation, ie,
InhA or KatG or both (InhA and katG) in isoniazid (INH) monoresistant mycobacteria and to …

Globally, extensive drug-resistant tuberculosis (XDR-TB) is a major element to cause
morbidity and death among tuberculosis patients. The present study identifies the vital risk …

MDR-TB is a tuberculosis disease resistant to the two most effective anti-TB drugs, rifampin
and isoniazid. MDR-TB is a threat to TB control. This study aims to identify the …

ABSTRAK TB MDR merupakan kasus TB yang disebabkan oleh resistensi bakteri
Mycobacterium tuberculosis terhadap isonizaid dan rifampisin dengan atau tanpa resisten …

Abstract Multidrug-Resistant Tuberculosis (MDR TB) is a condition when Mycobacterium
tuberculosis were resistant to Isoniazid and Rifampicin simultaneously, with or without being …

The aim of the study was to investigate behavior of resistant Mycobacterium tuberculosis
(MTB) isolates under a high dose of ofloxacin and its morphological changes. 19 extensively …

Introduction: Treatment failure and relapse rates are more likely to occur when there is
isoniazid (INH) resistance. So, we can no longer ignore the problem of isoniazid mono …

Over the most recent decades corporate reporting has proved to be essential to achieving
the strategic goals of humankinds and the ever-increasing necessity of truthful information …

Background: Multidrug-resistant tuberculosis (MDR-TB) is a global health challenge. The
emergence of MDR TB has contributed remarkably to the spread of tuberculosis and also …